Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2015) | Total Docs. (3years) | Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) |  Cites / Doc. (2years) |
Ref. / Doc. (2015) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Pulmonary Pharmacology and Therapeutics | journal | 1.015 Q2 | 81 | 110 | 260 | 5529 | 765 | 236 | 3.08 | 50.26 |  |
| 52 | Human Psychopharmacology | journal | 0.974 Q2 | 86 | 52 | 232 | 2845 | 657 | 227 | 3.03 | 54.71 |  |
| 53 | European Journal of Clinical Pharmacology | journal | 1.146 Q1 | 123 | 182 | 664 | 6280 | 2036 | 583 | 2.97 | 34.51 |  |
| 54 | PPAR Research | journal | 0.992 Q2 | 59 | 23 | 151 | 1800 | 379 | 144 | 2.94 | 78.26 | |
| 55 | Antimicrobial Resistance and Infection Control | journal | 1.093 Q1 | 66 | 56 | 101 | 1772 | 295 | 89 | 2.92 | 31.64 | |
| 56 | Pharmacotherapy | journal | 0.993 Q2 | 126 | 152 | 478 | 5245 | 1432 | 440 | 2.91 | 34.51 | |
| 57 | Targeted Oncology | journal | 1.400 Q1 | 59 | 54 | 113 | 2767 | 348 | 104 | 2.91 | 51.24 |  |
| 58 | Photodiagnosis and Photodynamic Therapy | journal | 0.746 Q2 | 67 | 77 | 228 | 2683 | 671 | 220 | 2.87 | 34.84 |  |
| 59 | Clinical Therapeutics | journal | 1.053 Q1 | 150 | 270 | 644 | 9992 | 1938 | 573 | 2.83 | 37.01 | |
| 60 | Journal of Aerosol Medicine and Pulmonary Drug Delivery | journal | 1.092 Q1 | 81 | 49 | 149 | 1700 | 453 | 144 | 2.83 | 34.69 | |
| 61 | Journal of Clinical Pharmacology | journal | 0.993 Q2 | 130 | 186 | 550 | 5879 | 1511 | 515 | 2.83 | 31.61 | |
| 62 | Cardiovascular Drugs and Therapy | journal | 1.238 Q1 | 79 | 68 | 204 | 3278 | 526 | 166 | 2.82 | 48.21 | |
| 63 | Advances in Therapy | journal | 0.843 Q2 | 83 | 90 | 241 | 3623 | 757 | 236 | 2.80 | 40.26 |  |
| 64 | Current Treatment Options in Oncology | journal | 1.202 Q1 | 66 | 58 | 143 | 3971 | 475 | 143 | 2.78 | 68.47 | |
| 65 | Vascular Health and Risk Management | journal | 0.900 Q2 | 82 | 62 | 224 | 3538 | 629 | 218 | 2.77 | 57.06 |  |
| 66 | Antiviral Therapy | journal | 1.388 Q1 | 93 | 107 | 425 | 3198 | 1177 | 409 | 2.76 | 29.89 | |
| 67 | Inflammopharmacology | journal | 1.031 Q2 | 68 | 32 | 113 | 1955 | 365 | 105 | 2.75 | 61.09 | |
| 68 | Pharmacoepidemiology and Drug Safety | journal | 1.908 Q1 | 109 | 164 | 586 | 4990 | 1608 | 517 | 2.73 | 30.43 | |
| 69 | Biopharmaceutics and Drug Disposition | journal | 0.733 Q2 | 65 | 52 | 149 | 1987 | 408 | 144 | 2.66 | 38.21 | |
| 70 | Expert Review of Neurotherapeutics | journal | 1.037 Q2 | 98 | 110 | 448 | 8907 | 1298 | 413 | 2.60 | 80.97 | |
| 71 | Expert Opinion on Emerging Drugs | journal | 1.051 Q2 | 54 | 50 | 125 | 4861 | 374 | 122 | 2.58 | 97.22 | |
| 72 | BMC pharmacology & toxicology | journal | 0.853 Q2 | 43 | 41 | 160 | 1456 | 393 | 154 | 2.57 | 35.51 | |
| 73 | Paediatric Drugs | journal | 0.855 Q2 | 70 | 50 | 142 | 3028 | 340 | 136 | 2.56 | 60.56 | |
| 74 | Cardiovascular Therapeutics | journal | 1.259 Q1 | 54 | 50 | 192 | 1995 | 578 | 181 | 2.50 | 39.90 | |
| 75 | American Journal of Cardiovascular Drugs | journal | 0.920 Q2 | 60 | 44 | 128 | 2273 | 322 | 121 | 2.49 | 51.66 | |
| 76 | Experimental and Clinical Psychopharmacology | journal | 1.373 Q1 | 101 | 54 | 173 | 2893 | 527 | 170 | 2.48 | 53.57 | |
| 77 | Annals of Pharmacotherapy | journal | 0.901 Q2 | 122 | 176 | 747 | 5475 | 1864 | 661 | 2.46 | 31.11 | |
| 78 | Contemporary Clinical Trials | journal | 1.249 Q1 | 75 | 216 | 440 | 10792 | 1113 | 419 | 2.44 | 49.96 | |
| 79 | Therapeutic Advances in Respiratory Disease | journal | 0.763 Q2 | 50 | 32 | 85 | 1302 | 225 | 75 | 2.44 | 40.69 | |
| 80 | Anti-Cancer Drugs | journal | 0.783 Q2 | 102 | 123 | 409 | 4015 | 934 | 402 | 2.42 | 32.64 | |
| 81 | Expert Review of Clinical Pharmacology | journal | 0.817 Q2 | 60 | 58 | 249 | 4113 | 574 | 215 | 2.41 | 70.91 | |
| 82 | Fundamental and Clinical Pharmacology | journal | 0.637 Q2 | 85 | 64 | 232 | 2798 | 485 | 232 | 2.39 | 43.72 | |
| 83 | Clinical Neuropharmacology | journal | 0.788 Q2 | 85 | 57 | 169 | 1544 | 394 | 162 | 2.24 | 27.09 | |
| 84 | Trials | journal | 1.235 Q1 | 98 | 594 | 1197 | 24419 | 2965 | 1176 | 2.23 | 41.11 | |
| 85 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.708 Q2 | 81 | 124 | 339 | 3722 | 717 | 334 | 2.22 | 30.02 | |
| 86 | Infection and Chemotherapy | journal | 0.597 Q2 | 38 | 44 | 198 | 1085 | 255 | 181 | 2.20 | 24.66 |  |
| 87 | Journal of Addiction Medicine | journal | 0.882 Q2 | 58 | 84 | 200 | 2099 | 418 | 190 | 2.20 | 24.99 | |
| 88 | Therapeutic Drug Monitoring | journal | 0.692 Q2 | 102 | 126 | 373 | 3459 | 833 | 330 | 2.19 | 27.45 | |
| 89 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 17 | 82 | 903 | 222 | 80 | 2.17 | 53.12 | | |
| 90 | Expert Review of Anticancer Therapy | journal | 0.795 Q2 | 85 | 127 | 473 | 8904 | 1016 | 449 | 2.07 | 70.11 | |
| 91 | HIV Research and Clinical Practice | journal | 54 | 28 | 100 | 890 | 211 | 97 | 2.05 | 31.79 | | |
| 92 | Therapeutic Advances in Psychopharmacology | journal | 43 | 56 | 116 | 1873 | 222 | 76 | 2.01 | 33.45 | | |
| 93 | PharmaNutrition | journal | 0.513 Q2 | 30 | 25 | 47 | 1425 | 94 | 43 | 2.00 | 57.00 | |
| 94 | Therapeutic Advances in Infectious Disease | journal | 0.477 Q3 | 29 | 2 | 24 | 161 | 48 | 21 | 2.00 | 80.50 | |
| 95 | Clinical Drug Investigation | journal | 0.664 Q2 | 67 | 97 | 346 | 2682 | 690 | 328 | 1.98 | 27.65 | |
| 96 | Current Therapeutic Research | journal | 0.557 Q2 | 46 | 21 | 91 | 530 | 160 | 86 | 1.95 | 25.24 | |
| 97 | International Journal of Breast Cancer | journal | 0.399 Q3 | 23 | 22 | 15 | 817 | 29 | 15 | 1.93 | 37.14 |  |
| 98 | Pharmacopsychiatry | journal | 0.654 Q2 | 84 | 52 | 162 | 1972 | 329 | 157 | 1.92 | 37.92 | |
| 99 | Journal of Ocular Pharmacology and Therapeutics | journal | 0.751 Q2 | 72 | 101 | 372 | 3634 | 691 | 342 | 1.90 | 35.98 | |
| 100 | Drug Metabolism and Pharmacokinetics | journal | 0.805 Q2 | 75 | 65 | 237 | 2463 | 584 | 218 | 1.89 | 37.89 |  |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data